FDA Investigator Ruark Lanham
Ruark Lanham has conducted inspections on 13 sites in 1 countries as of 29 Oct 2012. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
13
Last Inspection Date:
29 Oct 2012
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Ruark Lanham:
Barbara J Holladay,
Brian R Henderson,
Brooke K Higgins,
Brooke K Seeman,
Candice C Mandera,
Candice J Cortes,
Capri R Woolridge,
Caroline Strasinger,
Christine M Parmentier,
Christine M Whitby, CSO,
Chryste D Best,
Cindy W Lewis,
Cynthia F Kleppinger, MD,
Cynthia L Rakestraw,
David A Lum,
David K Glasgow,
Dianne H Milazzo,
Douglas A Campbell,
Eric L Dong, BS,
Erica L Nicoll,
Gary L Zaharek,
Gifford Whitehurst, Jr,
James M Simpson,
Janice R Small,
Jingbo Xiao,
Joey C West,
Jonathan W Chapman,
Jose R Hernandez,
Jude C Dikes,
Karen A Briggs,
Karen D Phung,
Kimberly A Dux,
Lawrence Harmon, Jr,
LCDR Margaret Edi Gennaro,
Linda Linh N Adams,
Lorna F Jones,
Luella J Rossi,
Luis A Dasta,
Marcus A Ray,
Qin Xu,
Randall P Zielinski,
Russell J Glapion,
Sean P Desbrow,
Stephanie L Shapley,
Steven B Chiu,
Timothy C Grome,
Wayne T Smith,
William H Linkroum
Ruark Lanham's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2000 | FDA 483 | Sybron Chemical Div - Form 483, 2000-03-10 |
March, 2000 | FDA 483 Response | Sybron Chemical Div - Form 483R, 2000-04-19 |
February, 2006 | FDA 483 | Taconic Farms, Inc. - Form 483, 2006-02-15 |
March, 2000 | EIR | Sybron Chemical Div - EIR, 2000-03-10 |
October, 2010 | FDA 483 | Promega Biosystems Sunnyvale, Inc. - Form 483, 2010-10-08 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more